<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38630952</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2332-7812</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Neurology(R) neuroimmunology &amp; neuroinflammation</Title><ISOAbbreviation>Neurol Neuroimmunol Neuroinflamm</ISOAbbreviation></Journal><ArticleTitle>Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19.</ArticleTitle><Pagination><StartPage>e200244</StartPage><MedlinePgn>e200244</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e200244</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1212/NXI.0000000000200244</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To report a case-control study of new-onset small fiber neuropathy (SFN) after COVID-19 with invasive cardiopulmonary exercise testing (iCPET). SFN is a critical objective finding in long COVID and amenable to treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective chart review was conducted on patients seen in the NeuroCOVID Clinic at Yale who developed new-onset SFN after a documented COVID-19 illness. We collected demographics, symptoms, skin biopsy, iCPET testing, treatments, and clinical response to treatment or no intervention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen patients were diagnosed with SFN on skin biopsy (median age 47, 75% female, 75% White). 92% of patients reported postexertional malaise characteristic of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and 7 patients underwent iCPET, which demonstrated neurovascular dysregulation and dysautonomia consistent with ME/CFS. Nine patients underwent treatment with IVIG, and 7 were not treated with IVIG. The IVIG group experienced significant clinical response in their neuropathic symptoms (9/9) compared with those who did not receive IVIG (3/7; <i>p</i> = 0.02).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Here, we present preliminary evidence that after COVID-19, SFN is responsive to treatment with IVIG and linked with neurovascular dysregulation and dysautonomia on iCPET. A larger clinical trial is indicated to further demonstrate the clinical utility of IVIG in treating postinfectious SFN.</AbstractText><AbstractText Label="CLASSIFICATION OF EVIDENCE" NlmCategory="METHODS">This study provides Class III evidence. It is a retrospective cohort study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McAlpine</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3652-5645</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (L.M., A.S.Z., S.S.), and Department of Pulmonology (P.J.), Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubair</LastName><ForeName>Adeel S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-9809-7888</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (L.M., A.S.Z., S.S.), and Department of Pulmonology (P.J.), Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9299-8629</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (L.M., A.S.Z., S.S.), and Department of Pulmonology (P.J.), Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spudich</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (L.M., A.S.Z., S.S.), and Department of Pulmonology (P.J.), Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurol Neuroimmunol Neuroinflamm</MedlineTA><NlmUniqueID>101636388</NlmUniqueID><ISSNLinking>2332-7812</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurol Neuroimmunol Neuroinflamm. 11:e200248.</RefSource><PMID Version="1">38630951</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071075" MajorTopicYN="Y">Small Fiber Neuropathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001342" MajorTopicYN="Y">Autonomic Nervous System Diseases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no relevant disclosures. Go to Neurology.org/NN for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>16</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38630952</ArticleId><ArticleId IdType="pmc">PMC11087026</ArticleId><ArticleId IdType="doi">10.1212/NXI.0000000000200244</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, et al. . Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1146. doi:10.1212/nxi.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Giannetti MP, Weller E, et al. . Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome. Neurol Sci. 2022;43(12):6627-6638. doi:10.1007/s10072-022-06423-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06423-y</ArticleId><ArticleId IdType="pmc">PMC9517969</ArticleId><ArticleId IdType="pubmed">36169757</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65(4):440-443. doi:10.1002/mus.27458</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CH, Bonyhay I, Benson A, Wang N, Freeman R. Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS One. 2013;8(12):e84716. doi:10.1371/journal.pone.0084716</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0084716</ArticleId><ArticleId IdType="pmc">PMC3874039</ArticleId><ArticleId IdType="pubmed">24386408</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Arevalo C, Oliveira RKF, et al. . Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160(2):642-651. doi:10.1016/j.chest.2021.01.082</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry NC, Manyoo A, Oldham WM, et al. . Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015;5(4):610-618. doi:10.1086/683815</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/683815</ArticleId><ArticleId IdType="pmc">PMC4671735</ArticleId><ArticleId IdType="pubmed">26697168</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BA, Cockrill BA, Waxman AB, Systrom DM. The invasive cardiopulmonary exercise test. Circulation. 2013;127(10):1157-1164. doi:10.1161/CIRCULATIONAHA.112.104463</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.104463</ArticleId><ArticleId IdType="pubmed">23479667</ArticleId></ArticleIdList></Reference><Reference><Citation>Trevino JA, Novak P. TS-HDS and FGFR3 antibodies in small fiber neuropathy and dysautonomia. Muscle Nerve. 2021;64(1):70-76. doi:10.1002/mus.27245</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27245</ArticleId><ArticleId IdType="pubmed">33792960</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Pari R, Miller S, et al. . Neurovascular dysregulation and acute exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, placebo-controlled trial of pyridostigmine. Chest. 2022;162(5):1116-1126. doi:10.1016/j.chest.2022.04.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.04.146</ArticleId><ArticleId IdType="pubmed">35526605</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. 2019;76(10):1240-1251. doi:10.1001/jamaneurol.2019.2917</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2917</ArticleId><ArticleId IdType="pmc">PMC10021074</ArticleId><ArticleId IdType="pubmed">31498378</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe8;ne D, Cacoub P, Authier FJ, et al. . Sj&#xf6;gren syndrome-associated small fiber neuropathy: characterization from a prospective series of 40 cases. Medicine (Baltimore). 2013;92(5):e10&#x2013;e18. doi:10.1097/md.0000000000000005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000000005</ArticleId><ArticleId IdType="pmc">PMC4553978</ArticleId><ArticleId IdType="pubmed">23982054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang M, Treister R, Oaklander AL. Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J Neurol. 2016;263(12):2515-2527. doi:10.1007/s00415-016-8270-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8270-5</ArticleId><ArticleId IdType="pmc">PMC5845263</ArticleId><ArticleId IdType="pubmed">27730378</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield JR, Hendrickson JE. Autoimmunity, autonomic neuropathy, and the HPV vaccination: a vulnerable subpopulation. Clin Pediatr (Phila). 2018;57(5):603-606. doi:10.1177/0009922817728701</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0009922817728701</ArticleId><ArticleId IdType="pubmed">28868890</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas MC. Guillain-Barr&#xe9; syndrome: the first documented COVID-19-triggered autoimmune neurologic disease: more to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e781. doi:10.1212/nxi.0000000000000781</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000000781</ArticleId><ArticleId IdType="pmc">PMC7309518</ArticleId><ArticleId IdType="pubmed">32518172</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas MC. Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy. Neurotherapeutics. 2021;18(4):2397-2418. doi:10.1007/s13311-021-01108-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-021-01108-4</ArticleId><ArticleId IdType="pmc">PMC8585501</ArticleId><ArticleId IdType="pubmed">34766257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>